Relationship between histologic response and the degree of tumor shrinkage after chemoradiotherapy in patients with locally advanced rectal cancer

Journal of Surgical Oncology

Volumn 109, Issue 7, 2014, Pages 659-664

  Suzuki, Toshiyuki ^a   Sadahiro, Sotaro ^a   Tanaka, Akira ^a   Okada, Kazutake ^a   Saito, Gota ^a   Kamijo, Akemi ^a   Akiba, Takeshi ^a   Kawada, Shuichi ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

chemoradiotherapy; histologic regression; rectal cancer; tumor shrinkage

Indexed keywords

GIMERACIL PLUS OTERACIL POTASSIUM PLUS TEGAFUR; UFT;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BARIUM ENEMA; CANCER REGRESSION; CANCER STAGING; CHEMORADIOTHERAPY; CORRELATION ANALYSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RECTUM CANCER; RECTUM RESECTION; TREATMENT RESPONSE; TUMOR VOLUME;

CHEMORADIOTHERAPY; HISTOLOGIC REGRESSION; RECTAL CANCER; TUMOR SHRINKAGE;

ADULT; AGED; AGED, 80 AND OVER; CHEMORADIOTHERAPY; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RECTAL NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84899538322     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23550     Document Type: Article

References (30)

1. Bosset JF, Collette L, Calais G, et al.: Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 2006; 355: 1114-1123.
2. Gerard JP, Conroy T, Bonnetain F, et al.: Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T 3-4 rectal cancers: Results of FFCD 9203. J Clin Oncol 2006; 24: 4620-4625.
3. Peeters KC, Marijnen CA, Nagtegaal ID, et al.: The TME trial after a median follow-up of 6 years: Increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg 2007; 246: 693-701.
4. Sauer R, Becker H, Hohenberger W, et al.: Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004; 351: 1731-1740.
5. Maas M, Nelemans PJ, Valentini V, et al.: Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: A pooled analysis of individual patient data. Lancet Oncol 2010; 11: 835-844.
6. Mohiuddin M, Hayne M, Regine WF, et al.: Prognostic significance of postchemoradiation stage following preoperative chemotherapy and radiation for advanced/recurrent rectal cancers. Int J Radiat Oncol Biol Phys 2000; 48: 1075-1080.
7. de Campos-Lobato LF, Stocchi L, da Luz Moreira A, et al.: Downstaging without complete pathologic response after neoadjuvant treatment improves cancer outcomes for cIII but not cII rectal cancers. Ann Surg Oncol 2010; 17: 1758-1766.
8. Kaminsky-Forrett MC, Conroy T, Luporsi E, et al.: Prognostic implications of downstaging following preoperative radiation therapy for operable T3-T4 rectal cancer. Int J Radiat Oncol Biol Phys 1998; 42: 935-941.
9. Suzuki T, Sadahiro S, Tanaka A, et al.: Biopsy specimens obtained 7 days after starting chemoradiotherapy (CRT) provide reliable predictors of response to CRT for rectal cancer. Int J Radiat Oncol Biol Phys 2013; 85: 1232-1238.
10. JSCCR: "Japanese Society for Cancer of the Colon and Rectum. Japanese classification of colorectal carcinoma." Tokyo: Kanehara, 1997.
11. Sadahiro S, Suzuki T, Tanaka A, et al.: Phase I/II study of preoperative concurrent chemoradiotherapy with S-1 for locally advanced, resectable rectal adenocarcinoma. Oncology 2011; 81: 306-311.
12. Mandard AM, Dalibard F, Mandard JC, et al.: Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations. Cancer 1994; 73: 2680-2686.
13. Suzuki T, Sadahiro S, Fukasawa M, et al.: Predictive factors of tumor shrinkage and histological regression in patients who received preoperative radiotherapy for rectal cancer. Jpn J Clin Oncol 2004; 34: 740-746.
14. Yeo SG, Kim DY, Kim TH, et al.: Tumor volume reduction rate measured by magnetic resonance volumetry correlated with pathologic tumor response of preoperative chemoradiotherapy for rectal cancer. Int J Radiat Oncol Biol Phys 2010; 78: 164-171.
15. Beer AJ, Wieder HA, Lordick F, et al.: Adenocarcinomas of esophagogastric junction: Multi-detector row CT to evaluate early response to neoadjuvant chemotherapy. Radiology 2006; 239: 472-480.
16. Lee SM, Kim SH, Lee JM, et al.: Usefulness of CT volumetry for primary gastric lesions in predicting pathologic response to neoadjuvant chemotherapy in advanced gastric cancer. Abdom Imaging 2009; 34: 430-440.
17. Pomerri F, Pucciarelli S, Gennaro G, et al.: Comparison between CT volume measurement and histopathological assessment of response to neoadjuvant therapy in rectal cancer. Eur J Radiol 2012; 81: 3918-3924.
18. Kang JH, Kim YC, Kim H, et al.: Tumor volume changes assessed by three-dimensional magnetic resonance volumetry in rectal cancer patients after preoperative chemoradiation: The impact of the volume reduction ratio on the prediction of pathologic complete response. Int J Radiat Oncol Biol Phys 2010; 76: 1018-1025.
19. Yeo SG, Kim DY, Park JW, et al.: Tumor volume reduction rate after preoperative chemoradiotherapy as a prognostic factor in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 2012; 82: e193-e199.
20. Patel UB, Brown G, Rutten H, et al.: Comparison of magnetic resonance imaging and histopathological response to chemoradiotherapy in locally advanced rectal cancer. Ann Surg Oncol 2012; 19: 2842-2852.
21. Kim SH, Lee JM, Hong SH, et al.: Locally advanced rectal cancer: Added value of diffusion-weighted MR imaging in the evaluation of tumor response to neoadjuvant chemo- and radiation therapy. Radiology 2009; 253: 116-125.
22. Lambregts DM, Vandecaveye V, Barbaro B, et al.: Diffusion-weighted MRI for selection of complete responders after chemoradiation for locally advanced rectal cancer: A multicenter study. Ann Surg Oncol 2011; 18: 2224-2231.
23. Capirci C, Rubello D, Pasini F, et al.: The role of dual-time combined 18-fluorodeoxyglucose positron emission tomography and computed tomography in the staging and restaging workup of locally advanced rectal cancer, treated with preoperative chemoradiation therapy and radical surgery. Int J Radiat Oncol Biol Phys 2009; 74: 1461-1469.
24. Leibold T, Akhurst TJ, Chessin DB, et al.: Evaluation of (18)F-FDG-PET for early detection of suboptimal response of rectal cancer to preoperative chemoradiotherapy: A prospective analysis. Ann Surg Oncol 2011; 18: 2783-2789.
25. Martoni AA, Di Fabio F, Pinto C, et al.: Prospective study on the FDG-PET/CT predictive and prognostic values in patients treated with neoadjuvant chemoradiation therapy and radical surgery for locally advanced rectal cancer. Ann Oncol 2011; 22: 650-656.
26. Onaitis MW, Noone RB, Fields R, et al.: Complete response to neoadjuvant chemoradiation for rectal cancer does not influence survival. Ann Surg Oncol 2001; 8: 801-806.
27. Hiotis SP, Weber SM, Cohen AM, et al.: Assessing the predictive value of clinical complete response to neoadjuvant therapy for rectal cancer: An analysis of 488 patients. J Am Coll Surg 2002; 194: 131-135; discussion 135-136.
28. Hayden DM, Jakate S, Pinzon MC, et al.: Tumor scatter after neoadjuvant therapy for rectal cancer: Are we dealing with an invisible margin ? Dis Colon Rectum 2012; 55: 1206-1212.
29. Eisenhauer EA, Therasse P, Bogaerts J, et al.: New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur J Cancer 2009; 45: 228-247.
30. Patel UB, Taylor F, Blomqvist L, et al.: Magnetic resonance imaging-detected tumor response for locally advanced rectal cancer predicts survival outcomes: MERCURY experience. J Clin Oncol 2011; 29: 3753-3760.